b cereus s aureus atcc 25923 (ATCC)
Structured Review
B Cereus S Aureus Atcc 25923, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 34630 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/atcc+25923+b+cereus/Staphylococcus+aureus+subsp%2E+aureus+Rosenbach/pm39852527-466-215-219
Average 99 stars, based on 34630 article reviews
Images
Related Articles
Activity Assay:Article Title: An Overview of the Potential Therapeutic Applications of Essential Oils Article Snippet: .. Antimicrobial activity Main Compound Structure Microorganism MIC/IC50 MBC/MFC Reference a,bAntibacterial Cinnamaldehyde Escherichia coli—S17 strain Methicillin-resistant S. aureus 200 μg/mL 400 μg/mL 0.3 mg/mL 0.5 mg/mL [50,53] Carvacrol Methicillin-resistant S. aureus E. coli—S17 strain S. mutans—ATCC 25175 A. actinomycetemcomitans—ATCC 33384 200 μg/mL 200 μg/mL 400 μg/mL 200 μg/mL 0.3 mg/mL 0.4 mg/mL 600 μg/mL 200 μg/mL [46,51,53,59] Thymol Methicillin-resistant S. aureus E. coli—S17 strain Methicillin-resistant S. aureus—ATCC 33591 E. coli—ATCC 10798 S. mutans ATCC 25175 A.actinomycetemcomitans—ATCC 33384 E. coli—ATCC 8739 S. aureus—ATCC 25923 B. cereus—ATCC 14579 S. typhimurium—ATCC 14028 200 μg/mL 200 μg/mL 200 μg/mL 200 μg/mL 200 μg/mL 100 μg/mL 7 μg/mL 7 μg/mL 7 μg/mL 3 μg/mL 0.3 mg/mL 0.3 mg/mL 200 μg/mL 400 μg/mL 400 μg/mL 200 μg/mL 0.12 mg/mL 0.12 mg/mL Bacterial growth 0.12 mg/mL [46,51–53,60] β-caryophyllene and Squalene β-caryophyllene Squalene Methicillin-resistant S. aureus E. coli—S17 strain >4000 μg/mL >4000 μg/mL >4.0 mg/mL >4.0 mg/mL [53] Terpineol E. coli—ATCC 8739 S. Article Title: An Overview of the Potential Therapeutic Applications of Essential Oils Article Snippet: .. Antimicrobial activity Main Compound Structure Microorganism MIC/IC50 MBC/MFC Reference a,bAntibacterial Cinnamaldehyde Escherichia coli—S17 strain Methicillin-resistant S. aureus 200 μg/mL 400 μg/mL 0.3 mg/mL 0.5 mg/mL [50,53] Carvacrol Methicillin-resistant S. aureus E. coli—S17 strain S. mutans—ATCC 25175 A. actinomycetemcomitans—ATCC 33384 200 μg/mL 200 μg/mL 400 μg/mL 200 μg/mL 0.3 mg/mL 0.4 mg/mL 600 μg/mL 200 μg/mL [46,51,53,59] Thymol Methicillin-resistant S. aureus E. coli—S17 strain Methicillin-resistant S. aureus—ATCC 33591 E. coli—ATCC 10798 S. mutans ATCC 25175 A.actinomycetemcomitans—ATCC 33384 E. coli—ATCC 8739 S. aureus—ATCC 25923 B. cereus—ATCC 14579 S. typhimurium—ATCC 14028 200 μg/mL 200 μg/mL 200 μg/mL 200 μg/mL 200 μg/mL 100 μg/mL 7 μg/mL 7 μg/mL 7 μg/mL 3 μg/mL 0.3 mg/mL 0.3 mg/mL 200 μg/mL 400 μg/mL 400 μg/mL 200 μg/mL 0.12 mg/mL 0.12 mg/mL Bacterial growth 0.12 mg/mL [46,51–53,60] β-caryophyllene and Squalene β-caryophyllene Squalene Methicillin-resistant S. aureus E. coli—S17 strain >4000 μg/mL >4000 μg/mL >4.0 mg/mL >4.0 mg/mL [53] Terpineol E. coli—ATCC 8739 S. Article Title: An Overview of the Potential Therapeutic Applications of Essential Oils Article Snippet: .. Antimicrobial activity Main Compound Structure Microorganism MIC/IC50 MBC/MFC Reference a,bAntibacterial Cinnamaldehyde Escherichia coli—S17 strain Methicillin-resistant S. aureus 200 μg/mL 400 μg/mL 0.3 mg/mL 0.5 mg/mL [50,53] Carvacrol Methicillin-resistant S. aureus E. coli—S17 strain S. mutans—ATCC 25175 A. actinomycetemcomitans—ATCC 33384 200 μg/mL 200 μg/mL 400 μg/mL 200 μg/mL 0.3 mg/mL 0.4 mg/mL 600 μg/mL 200 μg/mL [46,51,53,59] Thymol Methicillin-resistant S. aureus E. coli—S17 strain Methicillin-resistant S. aureus—ATCC 33591 E. coli—ATCC 10798 S. mutans ATCC 25175 A.actinomycetemcomitans—ATCC 33384 E. coli—ATCC 8739 S. aureus—ATCC 25923 B. cereus—ATCC 14579 S. typhimurium—ATCC 14028 200 μg/mL 200 μg/mL 200 μg/mL 200 μg/mL 200 μg/mL 100 μg/mL 7 μg/mL 7 μg/mL 7 μg/mL 3 μg/mL 0.3 mg/mL 0.3 mg/mL 200 μg/mL 400 μg/mL 400 μg/mL 200 μg/mL 0.12 mg/mL 0.12 mg/mL Bacterial growth 0.12 mg/mL [46,51–53,60] β-caryophyllene and Squalene β-caryophyllene Squalene Methicillin-resistant S. aureus E. coli—S17 strain >4000 μg/mL >4000 μg/mL >4.0 mg/mL >4.0 mg/mL [53] Terpineol E. coli—ATCC 8739 S. Article Title: An Overview of the Potential Therapeutic Applications of Essential Oils Article Snippet: Antimicrobial activity Main Compound Structure Microorganism MIC/IC50 MBC/MFC Reference a,bAntibacterial Cinnamaldehyde Escherichia coli—S17 strain Methicillin-resistant S. aureus 200 μg/mL 400 μg/mL 0.3 mg/mL 0.5 mg/mL [50,53] Carvacrol Methicillin-resistant S. aureus E. coli—S17 strain S. mutans—ATCC 25175 A. actinomycetemcomitans—ATCC 33384 200 μg/mL 200 μg/mL 400 μg/mL 200 μg/mL 0.3 mg/mL 0.4 mg/mL 600 μg/mL 200 μg/mL [46,51,53,59] Thymol Methicillin-resistant S. aureus E. coli—S17 strain Methicillin-resistant S. aureus—ATCC 33591 E. coli—ATCC 10798 S. mutans ATCC 25175 A.actinomycetemcomitans—ATCC 33384 E. coli—ATCC 8739 S. aureus—ATCC 25923 B. cereus—ATCC 14579 S. typhimurium—ATCC 14028 200 μg/mL 200 μg/mL 200 μg/mL 200 μg/mL 200 μg/mL 100 μg/mL 7 μg/mL 7 μg/mL 7 μg/mL 3 μg/mL 0.3 mg/mL 0.3 mg/mL 200 μg/mL 400 μg/mL 400 μg/mL 200 μg/mL 0.12 mg/mL 0.12 mg/mL Bacterial growth 0.12 mg/mL [46,51–53,60] β-caryophyllene and Squalene β-caryophyllene Squalene Methicillin-resistant S. aureus E. coli—S17 strain >4000 μg/mL >4000 μg/mL >4.0 mg/mL >4.0 mg/mL [53] Terpineol E. coli—ATCC 8739 S. aureus—ATCC 25923 B. cereus—ATCC 14579 S. typhimurium—ATCC 14028 60 μg/mL 30 μg/mL 120 μg/mL 120 μg/mL Bacterial growth 0.12 mg/mL Bacterial growth 0.25 [52,54] Methicillin-resistant S. aureus E. coli—S17 s rain S. mutans—ATCC 25175 A. actinomycetemcomitans —ATCC 33384 200 μg/mL 200 μg/mL 400 μg/mL 200 μg/mL 3 /mL 0.4 m /mL 6 μ /mL 200 μg/mL [46,51,53,59] Thymol Molecules 2020, 25, x FOR PEER REVIEW 6 of 26 Table 2. .. Antimicrobial activity of individual compounds from EO against different microorganis s. Antimicrobial activity Main Compound Structure Microorganism MIC/IC50 MBC/MFC Reference a,bAntibacterial Cin amaldehyde Es herichia coli—S17 strain Methi illin-resistant S. aureus 200 μg/mL 4 0 g/ 0.3 mg/mL 0.5 g/ [50,53] Carvacrol Methicillin-resistant S. aureus E. coli—S17 strain S. mutans—ATCC 25175 A. acti omycetemcomitans—ATCC 33384 200 μg/mL 2 0 g/ 4 0 g/ 2 0 g/ 0.3 mg/mL 0.4 g/ 600 μg/ 2 0 g/ [46,51,53,59] Thymol Methicillin-resistant S. aureus E. coli—S17 strain Methicillin-resistant S. aureus—ATCC 33591 E. coli—ATCC 10798 S. mutans AT C 25175 A.actinomycetemcomitans—ATCC 33384 E. oli—ATCC 8739 S. aureus—ATCC 25923 B. cereus TCC 14579 S. typhimurium—ATCC 14028 200 μg/mL 2 0 g/ 2 0 g/ 2 0 g/ 2 0 g/ 1 0 g/ 7 μg/mL 7 g/ 7 g/ 3 g/ 0.3 mg/mL 0.3 g/ 200 μg/ 4 0 g/ 4 0 g/ 2 0 g/ .12 mg/mL 0.12 g/ Bacterial growth 0.12 mg/mL [46,51–53,60] β-caryophyllene and Squalene β-caryophyllene Squalene Methicillin-resistant S. aureus E. coli—S17 strain >4000 μg/mL >4 0 g/ >4.0 g/ >4.0 g/ [53] Terpineol E. coli—ATCC 8739 S. Article Title: An Overview of the Potential Therapeutic Applications of Essential Oils Article Snippet: .. Antimicrobial activity Main Compound Structure Microorganism MIC/IC50 MBC/MFC Reference a,bAntibacterial Cinnamaldehyde Escherichia coli—S17 strain Methicillin-resistant S. aureus 200 μg/mL 400 μg/mL 0.3 mg/mL 0.5 mg/mL [50,53] Carvacrol Methicillin-resistant S. aureus E. coli—S17 strain S. mutans—ATCC 25175 A. actinomycetemcomitans—ATCC 33384 200 μg/mL 200 μg/mL 400 μg/mL 200 μg/mL 0.3 mg/mL 0.4 mg/mL 600 μg/mL 200 μg/mL [46,51,53,59] Thymol Methicillin-resistant S. aureus E. coli—S17 strain Methicillin-resistant S. aureus—ATCC 33591 E. coli—ATCC 10798 S. mutans ATCC 25175 A.actinomycetemcomitans—ATCC 33384 E. coli—ATCC 8739 S. aureus—ATCC 25923 B. cereus—ATCC 14579 S. typhimurium—ATCC 14028 200 μg/mL 200 μg/mL 200 μg/mL 200 μg/mL 200 μg/mL 100 μg/mL 7 μg/mL 7 μg/mL 7 μg/mL 3 μg/mL 0.3 mg/mL 0.3 mg/mL 200 μg/mL 400 μg/mL 400 μg/mL 200 μg/mL 0.12 mg/mL 0.12 mg/mL Bacterial growth 0.12 mg/mL [46,51–53,60] β-caryophyllene and Squalene β-caryophyllene Squalene Methicillin-resistant S. aureus E. coli—S17 strain >4000 μg/mL >4000 μg/mL >4.0 mg/mL >4.0 mg/mL [53] Terpineol E. coli—ATCC 8739 S. other:Article Title: An Overview of the Potential Therapeutic Applications of Essential Oils Article Snippet: , Terpineol , , Article Title: An Overview of the Potential Therapeutic Applications of Essential Oils Article Snippet: , Thymol , , Methicillin-resistant S. aureus E. coli —S17 strain Methicillin-resistant |
